Company: GVH
Filing Date: 2025-04-15
Form Type: DRS
Source: 0001641172-25-004806
Chunk: 64

Company: Globavend Holdings Ltd
Filing Date: 2025-04-15
Form: DRS
Chunk 64
---
 on company level.

We are a holding company incorporated in the Cayman Islands with no operating revenue or profit of our own. We rely on dividends paid to us by our subsidiaries for our cash requirements, including funds to pay any dividends and other cash distributions to our shareholders, service any debt we may incur, and pay our operating expenses. Our ability to pay dividends to our shareholders will depend on, among other things, the availability of dividends from our subsidiaries. According to the BVI Business Companies Act (as amended), a BVI company may make dividends distribution to the extent that immediately after the distribution, the value of the company’s assets exceeds its liabilities and that such company is able to pay its debts as they fall due. According to the Companies Ordinance of Hong Kong, a Hong Kong company may only make a distribution out of profits available for distribution. Under the current practice of the Inland Revenue Department of Hong Kong, no tax is payable in Hong Kong with respect to dividends paid by us.

Cash dividends, if any, on our Ordinary Shares will be paid in U.S. dollars.

<div align='center'>CAPITALIZATION</div>

The following table sets forth our cash and cash equivalents, debt and capitalization as of September 30, 2024:

| ● | on                                                                                                                              
 an actual basis;                                                                                                                |
| ● | on                                                                                                                              
 a pro-forma basis to give effect to the sale of 47,776 Ordinary Shares to Square Gate Master Fund, LLC – Series 1 as true-up    
 shares on November 7, 2024, pursuant to the Registration Statement on Form F-1 (File No. 333-280554); and                       |
| ● | on                                                                                                                              
 a pro-forma  as adjusted basis to give effect to the above and the issuance of [●] Ordinary Units in                            
 this Offering at an assumed public offering price of $[●] per Ordinary Unit, which is the closing price of our Ordinary         
 Shares on Nasdaq on [●], 2025, assuming no sales of Pre-Funded Units and no exercise of the Warrants issued in connection       
 with this Offering, after deducting underwriter discounts and commissions and estimated offering expenses payable by us, as set 
 forth in this prospectus.                                                                                                       |

You should read the following table in conjunction with the sections entitled “Use of Proceeds”and “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, and our financial statements and the related notes thereto included in our Annual Report,